{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:23:06Z","timestamp":1788909786681,"version":"build-2803163510"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014857","name":"National Natural Science Foundation of China-Guangdong Joint Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Nosocomial infections (NIs) are hospital-acquired infections which pose a high healthcare burden worldwide. The impact of NIs is further aggravated by the global spread of antimicrobial resistance (AMR). Conventional treatment and disinfection agents are often insufficient to catch up with the increasing AMR and tolerance of the pathogenic bacteria. This has resulted in a need for alternative approaches and raised new interest in therapeutic bacteriophages (phages). In contrast to the limited clinical options available against AMR bacteria, the extreme abundance and biodiversity of phages in nature provides an opportunity to establish an ever-expanding phage library that collectively provides sustained broad-spectrum and poly microbial coverage. Given the specificity of phage-host interactions, phage susceptibility testing can serve as a rapid and cost-effective method for bacterial subtyping. The library can also provide a database for routine monitoring of nosocomial infections as a prelude to preparing ready-to-use phages for patient treatment and environmental sterilization. Despite the remaining obstacles for clinical application of phages, the establishment of phage libraries, pre-stocked phage vials prepared to good manufacturing practice (GMP) standards, and pre-optimized phage screening technology will facilitate efforts to make phages available as modern medicine. This may provide the breakthrough needed to demonstrate the great potential in nosocomial infection management.<\/jats:p>","DOI":"10.3389\/fmicb.2021.638094","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:05:36Z","timestamp":1611824736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Potential of Therapeutic Bacteriophages in Nosocomial Infection Management"],"prefix":"10.3389","volume":"12","author":[{"given":"Nannan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"B1","year":"","journal-title":"Adaptive Phage Therapeutics Enters Agreement with Mayo Clinic to Commercialize a Phage Susceptibility Test."},{"key":"B2","year":"","journal-title":"Development Pipeline."},{"key":"B3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s0140-6736(10)61458-4","article-title":"Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.","volume":"377","author":"Allegranzi","year":"2011","journal-title":"Lancet"},{"key":"B4","year":"2020","journal-title":"In a first, Dr Dangs Lab begins bacteriophage susceptibility testing to combat antibiotic resistance."},{"key":"B5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3322\/caac.21462","article-title":"Update on infection control practices in cancer hospitals.","volume":"68","author":"Ariza-Heredia","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B6","year":"2020","journal-title":"Pipeline Overview."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients.","volume":"19","author":"Aslam","year":"2019","journal-title":"Am. J. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","article-title":"Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae.","volume":"9","author":"Bao","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijfoodmicro.2013.03.005","article-title":"Salmonella source attribution based on microbial subtyping.","volume":"163","author":"Barco","year":"2013","journal-title":"Int. J. Food Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/jcm.01595-06","article-title":"Comparison of multiple-locus variable-number tandem repeat analysis, pulsed-field gel electrophoresis, and phage typing for subtype analysis of Salmonella enterica serotype Enteritidis.","volume":"45","author":"Boxrud","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa.","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol. Med. Public Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41591-020-0894-4","article-title":"Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment.","volume":"26","author":"Chng","year":"2020","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1469-0691.2009.02969.x","article-title":"Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia.","volume":"16","author":"Cooke","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fm.2019.06.001","article-title":"Traditional Salmonella Typhimurium typing tools (phage typing and MLVA) are sufficient to resolve well-defined outbreak events only.","volume":"84","author":"Crabb","year":"2019","journal-title":"Food Microbiol."},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies.","volume":"83","author":"D\u00b4abrowska","year":"2019","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/1751-7915.13415","article-title":"Effective elimination of Staphylococcal contamination from hospital surfaces by a bacteriophage-probiotic sanitation strategy: a monocentric study.","volume":"12","author":"D\u2019Accolti","year":"2019","journal-title":"Microb. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1128\/jcm.41.9.4279-4284.2003","article-title":"Phage-based typing scheme for Salmonella enterica serovar Heidelberg, a causative agent of food poisonings in Canada.","volume":"41","author":"Demczuk","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2019.114976","article-title":"Evidence-based analysis on the toxicity of disinfection byproducts in vivo and in vitro for disinfection selection.","volume":"165","author":"Dong","year":"2019","journal-title":"Water Res."},{"key":"B20","article-title":"A case series of emergency investigational new drug applications for bacteriophages treating recalcitrant multi-drug resistant bacterial infections: confirmed safety and a signal of efficacy.","volume":"5","author":"Duplessis","year":"2019","journal-title":"J. Intensive Crit. Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02587","article-title":"Phenotypic and genotypic eligible methods for Salmonella typhimurium source tracking.","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00342","article-title":"The potential innovative use of bacteriophages within the DAC(\u00ae) hydrogel to treat patients with knee megaprosthesis infection requiring \u201cdebridement antibiotics and implant retention\u201d and soft tissue coverage as salvage therapy.","volume":"7","author":"Ferry","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1093\/jac\/dky263","article-title":"Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages.","volume":"73","author":"Ferry","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy.","volume":"11","author":"Gill","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/07315724.2018.1483783","article-title":"Bacteriophage for gastrointestinal health (PHAGE) study: evaluating the safety and tolerability of supplemental bacteriophage consumption.","volume":"38","author":"Gindin","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/gbe\/evv094","article-title":"As clear as mud? determining the diversity and prevalence of prophages in the draft genomes of estuarine isolates of clostridium difficile.","volume":"7","author":"Hargreaves","year":"2015","journal-title":"Genome Biol. Evol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev-micro-090817-062535","article-title":"Phage therapy in the twenty-first century: facing the decline of the antibiotic Era; is it finally time for the age of the phage?","volume":"73","author":"Hesse","year":"2019","journal-title":"Annu. Rev. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168380","article-title":"Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii in an intensive care unit.","volume":"11","author":"Ho","year":"2016","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.copbio.2020.08.016","article-title":"The future of phage biocontrol in integrated plant protection for sustainable crop production.","volume":"68","author":"Holtappels","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res. Microbiol."},{"key":"B31","year":"2020","journal-title":"Human Therapeutics-Intralytix, A Pioneer In Phage-Based Regulatory Approvals."},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial.","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131714","article-title":"Isolation and host range of bacteriophage with lytic activity against methicillin-resistant Staphylococcus aureus and potential use as a fomite decontaminant.","volume":"10","author":"Jensen","year":"2015","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria.","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01281-19","article-title":"A dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient.","volume":"64","author":"Kuipers","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions.","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial.","author":"Leitner","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-4939-7395-8_7","article-title":"Determination of the bacteriophage host range: culture-based approach.","volume":"1693","author":"Letarov","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance Era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.201904-0839le","article-title":"Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa.","volume":"200","author":"Maddocks","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.","volume":"249","author":"Malik","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","article-title":"A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds.","volume":"41","author":"Markoishvili","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/acs.accounts.8b00576","article-title":"Going viral: emerging opportunities for phage-based bacterial control in water treatment and reuse.","volume":"52","author":"Mathieu","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-Demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy.","volume":"6","author":"Mattila","year":"2015","journal-title":"Front. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1111\/1462-2920.14310","article-title":"Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers.","volume":"20","author":"McCallin","year":"2018","journal-title":"Environ. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/nejmc1912464","article-title":"Acquisition of antibiotic-resistant bacteria by U.S. International Travelers.","volume":"382","author":"Mellon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-7395-8_9","article-title":"Guidelines to compose an ideal bacteriophage cocktail.","volume":"1693","author":"Merabishvili","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s1473-3099(18)30714-x","article-title":"An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial.","volume":"19","author":"Mitchell","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.549084","article-title":"Bacteriophages of Helicobacter pylori.","volume":"11","author":"Mu\u00f1oz","year":"2020","journal-title":"Front Microbiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/cid\/ciz222","article-title":"Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination.","volume":"69","author":"Nir-Paz","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection.","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B52","year":"2020","journal-title":"Summary of Clinical Trials."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/07388551.2020.1805719","article-title":"Bacteriophages to control Shiga toxin-producing E. coli - safety and regulatory challenges.","volume":"40","author":"Pinto","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy.","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s11095-010-0313-5","article-title":"The phage therapy paradigm: pr\u00eat-\u00e0-porter or sur-mesure?","volume":"28","author":"Pirnay","year":"2011","journal-title":"Pharm. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1128\/cmr.00016-17","article-title":"Whole-Genome sequencing of bacterial pathogens: the future of nosocomial outbreak analysis.","volume":"30","author":"Quainoo","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13391","article-title":"Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy.","author":"Rostkowska","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1462-2920.13574","article-title":"Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.","volume":"19","author":"Sarker","year":"2017","journal-title":"Environ. Microbiol."},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection.","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cca.2017.08.035","article-title":"Traditional approaches versus mass spectrometry in bacterial identification and typing.","volume":"473","author":"Sloan","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01711","article-title":"Phenotypic and genetic predictors of pathogenicity and virulence in Flavobacterium psychrophilum.","volume":"10","author":"Sundell","year":"2019","journal-title":"Front. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7080237","article-title":"Development of a biocontrol method applying bacteriophage-containing aerosol against Mycobacterium tuberculosis using the bacteriophage BTCU-1 and M. smegmatis as models.","volume":"7","author":"Tseng","year":"2019","journal-title":"Microorganisms"},{"key":"B64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-9118-1_2","article-title":"Genotyping of Acinetobacter baumannii in nosocomial outbreak and surveillance.","volume":"1946","author":"Vijayakumar","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B65","doi-asserted-by":"crossref","first-page":"A72","DOI":"10.1016\/j.ajic.2019.03.016","article-title":"Continuous room decontamination technologies.","author":"Weber","year":"2019","journal-title":"Am. J. Infect. Control"},{"key":"B66","year":"2017","journal-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics."},{"key":"B67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.","volume":"34","author":"Wright","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/currents.outbreaks.aa5372d90826e6cb0136ff66bb7a62fc","article-title":"Whole genome sequence analysis of salmonella enteritidis PT4 outbreaks from a national reference laboratory\u2019s viewpoint.","volume":"7","author":"Wuyts","year":"2015","journal-title":"PLoS Curr."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050269","article-title":"The israeli phage bank (IPB).","volume":"9","author":"Yerushalmy","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01056","article-title":"Phage therapy in poland \u2013 a centennial journey to the first ethically approved treatment facility in Europe.","volume":"11","author":"\u017baczek","year":"2020","journal-title":"Front. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ani10050872","article-title":"The use of bacteriophages in the poultry industry.","volume":"10","author":"\u017bbikowska","year":"2020","journal-title":"Animals (Basel)"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.638094\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:05:41Z","timestamp":1611824741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.638094\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":71,"alternative-id":["10.3389\/fmicb.2021.638094"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.638094","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"article-number":"638094"}}